Short answer
Assembly Biosciences Inc (ASMB) filed its Q3 2026 10-Q quarterly report on Nov 12, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $3M (down 72.6% year over year) with net income of −$20M.
Q3 2026 key financials · XBRL
- Revenue
- $3M
- −72.6% YoY · −77.9% QoQ
- Net income
- −$20M
- −120.3% YoY · −425.2% QoQ
- Operating margin
- -792.1%
- EPS (diluted)
- −$1.01
- −94.2% YoY · −461.1% QoQ
Source: XBRL data from the Assembly Biosciences Inc (ASMB) Q3 2026 10-Q on SEC EDGAR. USD.
Assembly Biosciences Inc Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 collaboration revenue $3.0M, down 73% YoY from $10.8M
- Q3 R&D expenses $20.2M vs $16.6M YoY, driven by 6250 trial startups
- Best program momentum: 6250 Phase 2 HDV dosing initiated; CLD Phase 2 planned for Q1 2027
- Operating cash used $54.7M through September, cash and securities $314.3M at September 30
- Outlook: funds expected to support operations into 2029, including Gilead’s $75.0M extension payment
Risk Factors
- Newly added regulatory risk: FDA workforce downsizing and eliminated positions could delay inspections, reviews, guidance, and approvals
- Most materially updated collaboration risk: Gilead declined 4334 licensing in March 2026, potentially slowing development and commercialization
- Data privacy compliance risk: EU and UK GDPR violations can trigger fines up to €20 million, £17.5 million, or 4% of global revenue
- Operational risk: Foreign CROs and suppliers face China scrutiny, tariffs, geopolitical disruptions, and supply-chain interruptions
- Financial risk: Gilead owned approximately 24.4% of common stock and may increase ownership to 35%
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Assembly Biosciences Inc quarterly reports
- Q3 2019 10-QFiled Nov 7, 2019
- Q2 2019 10-QFiled Aug 5, 2019
- Q1 2019 10-QFiled May 9, 2019
- Q3 2018 10-QFiled Nov 8, 2018
- Q2 2018 10-QFiled Aug 8, 2018
- Q1 2018 10-QFiled May 7, 2018
- Q3 2017 10-QFiled Nov 1, 2017
- Q2 2017 10-QFiled Aug 9, 2017
- Q1 2017 10-QFiled May 8, 2017
- Q3 2016 10-QFiled Nov 9, 2016
- Q2 2016 10-QFiled Aug 9, 2016
- Q1 2016 10-QFiled May 10, 2016
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.